LMWE:F:F-Lyxor FTSE EPRA/NAREIT Global Developed UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 44

Change

-0.22 (-0.50)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.29 (+1.03%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.83 (+3.51%)

USD 114.02B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.40 (-0.07%)

USD 104.81B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+3.05 (+5.47%)

USD 94.20B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.94 (+6.21%)

USD 53.41B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.44 (-0.40%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.95 (+1.20%)

USD 50.88B
XJSE:F Xtrackers II - Japan Governmen..

+0.01 (+0.16%)

USD 40.35B
0ZC:F Zscaler Inc

-6.48 (-3.33%)

USD 37.92B

ETFs Containing LMWE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.19% 52% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.19% 48% F 49% F
Trailing 12 Months  
Capital Gain 13.74% 55% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.74% 51% F 49% F
Trailing 5 Years  
Capital Gain -9.27% 17% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.27% 15% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain 1.87% 41% F 47% F
Dividend Return 1.87% 39% F 42% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.66% 30% F 72% C
Risk Adjusted Return 10.56% 34% F 42% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.